Teva- Pharmaceutical Industries Ltd (TEVA) Unusual Options Activity Today

Checking TEVA unusual options activity helps you spot when traders are making outsized bets on Teva- Pharmaceutical Industries Ltd before the broader market catches on. Teva- Pharmaceutical Industries Ltd's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor TEVA unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching TEVA unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking TEVA unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and TEVA unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas.

Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Catalysts rarely arrive without a footprint, and TEVA unusual options activity is often where that footprint shows up first. Our scanner tracks Teva- Pharmaceutical Industries Ltd's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at TEVA unusual options volume on the call side or chasing put sweeps, Teva- Pharmaceutical Industries Ltd's unusual options flow today is one click away, so put it on your radar before the headlines hit.